TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32370545

Group type: EXPERIMENTAL
Intervention: TrPDN + PNE (6 sessions of dry needling with 3 sessions of pain neuroscience education), n=21
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DN alone (6 sessions of dry needling), n=20
Number of subjects: 60

Group type: COMPARATOR
Intervention: CUC (10 sessions of usual care), n=19
Number of subjects: 60
Study: 35201358

Group type: EXPERIMENTAL
Intervention: Fentanyl (1 μg/kg intravenous)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 34
Study: 32459005

Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered 6 months after last denosumab injection (6M group, n = 20)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered 9 months after last denosumab injection (9M group, n = 20)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered when bone turnover had increased (OBS group, n = 21)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study: 35144532

Group type: EXPERIMENTAL
Intervention: Recruitment method: word of mouth
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Recruitment method: press media
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Screening phase exclusion reason
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Eligibility criteria exclusion
Number of subjects: 220
Study: 32251023

Group type: COMPARATOR
Intervention: Rimegepant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ubrogepant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vazegepant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atogepant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rimegepant and Ubrogepant
Number of subjects: 0
Study: 35230864

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhibitory theta burst stimulation (iTBS)
Number of subjects: 0
Study: 32335132

Group type: EXPERIMENTAL
Intervention: 10-minute RHD duration
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 20-minute RHD duration
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 30-minute RHD duration
Number of subjects: 450
Study: 33029128

Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left DLPFC
Number of subjects: 55
Study: 33649927

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autogenous fat graft (AFG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collagen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaginal wall injection
Number of subjects: 0
Study: 33754861

Group type: EXPERIMENTAL
Intervention: Inoculated with Pythium myriotylum isolates (two 5-mm mycelial plugs from active growing cultures)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (inoculated with blank PDA plugs)
Number of subjects: 8
Study: 32776693

Group type: EXPERIMENTAL
Intervention: Break Binge Eating online platform
Number of subjects: 786
Study: 33835051

Group type: EXPERIMENTAL
Intervention: UDCA + Mesalazine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 40
Study: 34274495

Group type: EXPERIMENTAL
Intervention: Nutrition and exercise intervention delivered by registered dietitians specializing in oncology nutrition and exercise training, consisting of goal setting to meet nutrition and physical activity guidelines for cancer survivors, over a yearlong period with 16 sessions.
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Nutrition and exercise intervention
Number of subjects: 172
Study: 32629506

Group type: EXPERIMENTAL
Intervention: 20-min nap after sleep deprivation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sleep deprivation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal sleep
Number of subjects: 11
Study: 36224375

Group type: EXPERIMENTAL
Intervention: UPBEAT intervention (n = 31)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care arm (n = 39)
Number of subjects: 39
Study: 33283667

Group type: EXPERIMENTAL
Intervention: End-to-side anastomosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Side-to-side anastomosis
Number of subjects: 100
Study: 35981118

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI), 8-week personalized yoga therapy.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 45
Study: 33704052

Group type: EXPERIMENTAL
Intervention: Orally disintegrating film of varenicline salicylate (test drug)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Film‐coated tablets of varenicline tartrate (reference drug)
Number of subjects: 28
Study: 32717999

Group type: EXPERIMENTAL
Intervention: 300 mg mango leaf extract (Zynamite®)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 70
Study: 33657755

Group type: EXPERIMENTAL
Intervention: WBV-30 (30 Hz, low amplitude)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: WBV-50 (50 Hz, low amplitude)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No-WBV
Number of subjects: 14
Study: 33291798

Group type: EXPERIMENTAL
Intervention: Tryptamines (5‐MeO‐DiPT, 5‐MeO‐DALT, DMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analytical methods (liquid chromatography tandem mass spectrometry)
Number of subjects: 0
Study: 35389303

Group type: EXPERIMENTAL
Intervention: Calendula officinalis L.
Number of subjects: 0
Study: 32967390

Group type: EXPERIMENTAL
Intervention: Intradiscal ozone therapy (Group 1)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Intradiscal ozone therapy with periforaminal steroid injection (Group 2)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Comparison between Group 1 and Group 2
Number of subjects: 65
Study: 35916802

Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120
Study: 33220004

Group type: EXPERIMENTAL
Intervention: BAG
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BAG + Er:YAG laser
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Er:YAG laser + BAG
Number of subjects: 120

Group type: COMPARATOR
Intervention: Deionized water (Control)
Number of subjects: 120
Study: 36172861

Group type: EXPERIMENTAL
Intervention: Quarterly antibiotic-prescribing feedback reports
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 340
Study: 33871558

Group type: EXPERIMENTAL
Intervention: LEU-PRO (3 g leucine, 10 g protein; n=38)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: LEU-PRO+n-3 (0.8 g EPA, 1.1 g DHA; n=38)
Number of subjects: 107

Group type: COMPARATOR
Intervention: CON (isoenergetic control; n=31)
Number of subjects: 107
Study: 32868798

Group type: EXPERIMENTAL
Intervention: MTX plus rhTNFR:Fc for 52 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: MTX plus rhTNFR:Fc for 24 weeks
Number of subjects: 89

Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 89
Study: 35683566

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback (EMG-BF) added to conventional rehabilitation program
Number of subjects: 131

Group type: COMPARATOR
Intervention: Conventional rehabilitation program without EMG-BF
Number of subjects: 131
Study: 32507027

Group type: EXPERIMENTAL
Intervention: High-Intensity Variable Stepping Training (HV)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-Intensity Forward Walking Training (HF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-Intensity Variable Stepping Training (LV)
Number of subjects: 50
Study: 33433151

Group type: COMPARATOR
Intervention: High‐intensity interval exercise (HIIE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Circuit resistance exercise (CRE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Moderate‐intensity continuous exercise (MICE)
Number of subjects: 10
Study: 34309743

Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM) intervention for two years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Community resources (Control)
Number of subjects: 0
Study: 33657333

Group type: EXPERIMENTAL
Intervention: Research articles reporting an intervention
Number of subjects: 537

Group type: COMPARATOR
Intervention: Research articles including a comparison
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Articles with identified research methodology
Number of subjects: 537

Group type: COMPARATOR
Intervention: Random assignment to experimental or control conditions
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Qualitative inquiry methodology
Number of subjects: 537
Study: 32483861

Group type: EXPERIMENTAL
Intervention: Bioelectric impedance spectroscopy (BIS)
Number of subjects: 508

Group type: COMPARATOR
Intervention: Tape measure (TM)
Number of subjects: 508
Study: 36444922

Group type: EXPERIMENTAL
Intervention: Preoperative thromboelastography (TEG)
Number of subjects: 284
Study: 33048249

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm predicting ODI after treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of actual patient values after 6 months with predictions for alternative therapy
Number of subjects: 60
Study: 32583971

Group type: EXPERIMENTAL
Intervention: Educational video and booklet
Number of subjects: 221

Group type: COMPARATOR
Intervention: Booklet alone
Number of subjects: 221
Study: 35715180

Group type: EXPERIMENTAL
Intervention: SMART Mental Health intervention integrating a community-level stigma reduction campaign and task sharing with a mobile-enabled electronic decision support system (EDSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clusters (not specified what the control intervention is)
Number of subjects: 0
Study: 35010577

Group type: EXPERIMENTAL
Intervention: Differential Learning (DL) with external focus
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Differential Learning (DL) with internal focus
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Differential Learning (DL) with no focus
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Traditional training with external focus
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional training with control groups
Number of subjects: 40
Study: 36135380

Group type: EXPERIMENTAL
Intervention: CCP with nAb titers of >1:640 (high-titer group)
Number of subjects: 55

Group type: COMPARATOR
Intervention: CCP with nAb titers of ≥1:160 to 1:640 (standard-titer group)
Number of subjects: 55
Study: 33764167

Group type: EXPERIMENTAL
Intervention: Acute dietary nitrate supplementation (high nitrate beverage)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (nitrate depleted beverage)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mental stress challenge
Number of subjects: 11
Study: 32332590

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with music (CBT-music)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 83
Study: 35088219

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 1299

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1299
Study: 33400421

Group type: EXPERIMENTAL
Intervention: Nutrafol® Women’s Balance Capsules
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 35822412

Group type: EXPERIMENTAL
Intervention: 40 mg esomeprazole magnesium (test)
Number of subjects: 75

Group type: COMPARATOR
Intervention: 40 mg esomeprazole magnesium (reference)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Esomeprazole administered while fed
Number of subjects: 75
Study: 32853704

Group type: EXPERIMENTAL
Intervention: Naturalistic developmental/behavioral intervention style, 25 hours per week for 12 months
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Naturalistic developmental/behavioral intervention style, 15 hours per week for 12 months
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Discrete trial teaching intervention style, 25 hours per week for 12 months
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Discrete trial teaching intervention style, 15 hours per week for 12 months
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Treatment intensity (25 hours per week)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Treatment intensity (15 hours per week)
Number of subjects: 87
Study: 36043033

Group type: EXPERIMENTAL
Intervention: Predictive nursing with early active function exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Basic nursing methods only (control)
Number of subjects: 80
Study: 33001255

Group type: EXPERIMENTAL
Intervention: Daily probiotic group (Lactobacillus paracasei SD1 once daily)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Triweekly probiotic group (Lactobacillus paracasei SD1 3 days a week)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 268
Study: 34329355

Group type: EXPERIMENTAL
Intervention: Couple Oriented Counselling (COC)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Classical counselling
Number of subjects: 484
Study: 33074709

Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (TUDCA) 1,500 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (TUDCA)
Number of subjects: 12
Study: 34455355

Group type: EXPERIMENTAL
Intervention: Unedited selfies with labels
Number of subjects: 350

Group type: COMPARATOR
Intervention: Edited selfies
Number of subjects: 350
Study: 36389724

Group type: EXPERIMENTAL
Intervention: Anti-PD-1 adjuvant therapy (intravenous injection of 200 mg, repeated every 3 weeks for a total of 4 or 8 cycles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no anti-PD-1 therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-PD-1 adjuvant therapy
Number of subjects: 0
Study: 34349378

Group type: EXPERIMENTAL
Intervention: CMAC video laryngoscope (Mac 3)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 87
Study: 34781136

Group type: EXPERIMENTAL
Intervention: 1500 IU nano-encapsulated vitamin D fortified yogurt
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 35309285

Group type: EXPERIMENTAL
Intervention: LAMA/LABA
Number of subjects: 6266

Group type: COMPARATOR
Intervention: LAMA/LABA/ICS
Number of subjects: 6266
Study: 33218502

Group type: EXPERIMENTAL
Intervention: Core stabilization exercises
Number of subjects: 32

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation and hot-pack (Control)
Number of subjects: 32
Study: 36011661

Group type: EXPERIMENTAL
Intervention: Graphic message on health rewards
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Graphic message on social norms
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Graphic message on autonomy
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Graphic message on financial rewards
Number of subjects: 362
Study: 32360038

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI) with everolimus‐eluting stents
Number of subjects: 1893

Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: Never smokers
Number of subjects: 1893
Study: 35429132

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Levetiracetam (LEV)
Number of subjects: 271
Study: 33533681

Group type: EXPERIMENTAL
Intervention: Moderate ability discrepancy partner (MP)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Individual no-partner control
Number of subjects: 176
Study: 32312223

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564
Study: 34705136

Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Air Insufflation (C)
Number of subjects: 284
Study: 33144712

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 100
Study: 34763295

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pelvic Floor Muscle Training (PFMT)
Number of subjects: 30
Study: 34291862

Group type: EXPERIMENTAL
Intervention: Smartphone fundoscopy (D‐eye or iExaminer)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Direct ophthalmoscopy (Welch Allyn)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Smartphone fundoscopy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: E-learning support
Number of subjects: 102
Study: 35136033

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics (haloperidol or perphenazine)
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Combination of PRS and clinical data
Number of subjects: 2040
Study: 33539993

Group type: EXPERIMENTAL
Intervention: FBT plus Parent‐focused CRT
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: FBT plus Adolescent‐focused CRT
Number of subjects: 54

Group type: COMPARATOR
Intervention: FBT only
Number of subjects: 54
Study: 33618070

Group type: EXPERIMENTAL
Intervention: Specific Memory Attention Resource and Training (SMART) application, 10 min per day, five days per week for three months.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 80
Study: 32573161

Group type: EXPERIMENTAL
Intervention: Fixed platform prosthesis
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Mobile platform prosthesis
Number of subjects: 86
Study: 35113330

Group type: EXPERIMENTAL
Intervention: Orsiro ultrathin struts biodegradable polymer sirolimus‐eluting stents (O‐SES)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Xience thin struts durable polymer everolimus‐eluting stents (X‐EES)
Number of subjects: 49
Study: 34509613

Group type: EXPERIMENTAL
Intervention: Virtual Visits (VV)
Number of subjects: 442

Group type: COMPARATOR
Intervention: In-person visits
Number of subjects: 442

Group type: COMPARATOR
Intervention: Crossover (randomized to virtual but completed in-person)
Number of subjects: 442
Study: 35500260

Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 0
Study: 34655859

Group type: EXPERIMENTAL
Intervention: Fat-negative media content
Number of subjects: 525

Group type: COMPARATOR
Intervention: Fat-positive media content
Number of subjects: 525
Study: 35466432

Group type: EXPERIMENTAL
Intervention: Immediate skin-to-skin contact with a parent for the first six postnatal hours
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard incubator care
Number of subjects: 91
Study: 33544305

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg with a 240 mg loading dose
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 2886

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 2886
Study: 33166719

Group type: EXPERIMENTAL
Intervention: Camrelizumab 200 mg every 2 weeks plus apatinib 375 mg once daily (QD), 5 days on and 2 days off
Number of subjects: 59
Study: 33017212

Group type: EXPERIMENTAL
Intervention: Leaflet resection
Number of subjects: 104

Group type: COMPARATOR
Intervention: Leaflet preservation
Number of subjects: 104
Study: 35707974

Group type: EXPERIMENTAL
Intervention: 500‐mL intravenous fluid bolus
Number of subjects: 1067

Group type: COMPARATOR
Intervention: No fluid bolus
Number of subjects: 1067
Study: 33657849

Group type: EXPERIMENTAL
Intervention: Mechanical Thrombectomy (MT)
Number of subjects: 1026

Group type: COMPARATOR
Intervention: Combined Intravenous Thrombolysis (IVT) and Mechanical Thrombectomy (MT)
Number of subjects: 1026
Study: 36405842

Group type: EXPERIMENTAL
Intervention: FTF/CD
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: RD/CD
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: RD/eSLD
Number of subjects: 110

Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 110
Study: 32045493

Group type: EXPERIMENTAL
Intervention: TAK-079 (0.06 mg/kg i.v.)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: TAK-079 (0.6 mg/kg s.c.)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: TAK-079 (≥0.3 mg/kg s.c.)
Number of subjects: 74
Study: 35122365

Group type: EXPERIMENTAL
Intervention: MS-Spasticity App
Number of subjects: 115

Group type: COMPARATOR
Intervention: Paper-based self-training program
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: MIR
Number of subjects: 115
Study: 33586924

Group type: EXPERIMENTAL
Intervention: 30 minutes of mental exertion (EXP) by Stroop task
Number of subjects: 15

Group type: COMPARATOR
Intervention: 30 minutes without mental exertion (CON)
Number of subjects: 15
Study: 32946668

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (matched group who did not receive tocilizumab)
Number of subjects: 29
Study: 36076211

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (1000 mg dose at enrolment)
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Oral ferrous sulphate (195 mg elemental iron daily, thrice daily from enrolment till 6 weeks postpartum)
Number of subjects: 1056
Study: 34152835

Group type: EXPERIMENTAL
Intervention: Compassion-Centered Spiritual Health Team Intervention (CCSH-TI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 41
Study: 32499262

Group type: EXPERIMENTAL
Intervention: NAVIGATE intervention (individualised medication management, individual resiliency training, supported employment and education, family education)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: NAVIGATE intervention
Number of subjects: 400
Study: 35879178

Group type: EXPERIMENTAL
Intervention: BoNTA (5U/0.05 mL)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lateral Tarsal Strip (LTS)
Number of subjects: 25